Section Navigation
Section Navigation
- Module 2 Overview
HIV PrEP In-Depth Topics - 0%Lesson 1
HIV PrEP for Adolescents and Young AdultsActivities- 0%Lesson 2
HIV PrEP for Transgender and Gender-Diverse PeopleActivities- 0%Lesson 3
HIV PrEP for Cisgender Women and Pregnant PersonsActivities- 0%Lesson 4
HIV PrEP for People Who Inject DrugsLesson 3. HIV PrEP for Cisgender Women and Pregnant Persons
Learning Objective Performance Indicators
- Explain how structural and intimate partner violence impacts the risk for HIV acquisition among cisgender women and pregnant persons
- Provide a rationale for prescribing HIV PrEP for cisgender women of childbearing age
- Summarize the HIV epidemiology, clinical trial evidence, and indications that support the use of HIV PrEP in cisgender women and in pregnant people
- Explore the risks and benefits of using HIV PrEP in pregnant persons during the periconception period, pregnancy, or with breastfeeding
- Discuss the clinical management of HIV PrEP for cisgender women and pregnant persons including sexual history, baseline evaluation, HIV PrEP medications, follow-up monitoring, and adherence
About this Lesson
Learning Objective Performance Indicators
- Explain how structural and intimate partner violence impacts the risk for HIV acquisition among cisgender women and pregnant persons
- Provide a rationale for prescribing HIV PrEP for cisgender women of childbearing age
- Summarize the HIV epidemiology, clinical trial evidence, and indications that support the use of HIV PrEP in cisgender women and in pregnant people
- Explore the risks and benefits of using HIV PrEP in pregnant persons during the periconception period, pregnancy, or with breastfeeding
- Discuss the clinical management of HIV PrEP for cisgender women and pregnant persons including sexual history, baseline evaluation, HIV PrEP medications, follow-up monitoring, and adherence
Activities in this Lesson
- Quick ReferenceHIV PrEP for Cisgender Women and Pregnant Persons Core Concepts
- Background
- Epidemiology of HIV in Cisgender Women
- Evidence for HIV PrEP in Cisgender Women
- Evidence for HIV PrEP in Pregnant People and During Breastfeeding
- HIV PrEP Indications for Cisgender Women and Pregnant People
- Recommended HIV PrEP Medication Options for Cisgender Women and Pregnant People
- Interaction of HIV PrEP Medications with Hormonal Contraception
- Baseline Laboratory Evaluation
- Time to Achieve Protection After Initiating PrEP
- Follow-Up and Laboratory Monitoring
- Summary Points
Share by e-mail
Check
-On-
Learning
QuestionsThe Check-on-Learning Questions are short and topic related. They are meant to help you stay on track throughout each lesson and check your understanding of key concepts.You must be signed in to customize your interaction with these questions.
- 0%Lesson 2
The National HIV PrEP Curriculum is supported by the Centers for Disease Control and Prevention (CDC) and the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $625,000 from CDC and $300,005 from HRSA with 0% financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC, HRSA, HHS, or the U.S. Government. This project is led by the University of Washington Infectious Diseases Education & Assessment (IDEA) Program.
Since you've received 80% or better on this quiz, you may claim continuing education credit.
You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.
Current Version: prepc-MR-feature-666-certificates-sh-ea81c640-2024-05-08-193240
Become a New User
Account Registration Benefits:
- Track your progress on the 11 lessons
- Earn free CNE/CME/CE
- Earn Certificates of Completion
- Access to other free IDEA curricula
Create a free account to get started